Company News

Persistent to buy German digital engg firm Nagarro, expand Europe presence

The all-cash acquisition, backed by Nagarro's largest shareholder, will expand Persistent's European presence and is expected to take combined annual revenue to about $2.9 billion

US judge seeks reasons for dropping criminal charges against Gautam Adani

The Justice Department said last month it would no longer pursue the prosecution

Alstom gets €107 mn loco maintenance contract renewal from Railways

The five-year contract covers maintenance of 250 WAG-12B locomotives at Alstom's Nagpur depot under a renewed agreement with its joint venture with Indian Railways

Micromax-Phison JV MiPhi first to manufacture enterprise SSDs locally

Micromax-Phison JV making these advanced data-storage solutions at its Noida plant

Legal review reveals ex-chairman's charges 'not substantiated': HDFC Bank

Atanu Chakraborty didn't participate in the review, ignoring requests from the external law firms

ITC's FMCG business clocks consumer spend of over ₹37,000 cr in FY26

ITC's non-cigarette FMCG portfolio crossed Rs 37,000 crore in annual consumer spend in FY26, driven by strong brand growth, acquisitions and rising household reach

Byju's lenders seek nearly 30% stake in Aakash under settlement talks

Global lenders are in advanced talks to take a stake in Aakash Educational Services and withdraw legal action against Byju's founder Byju Raveendran

Foxconn Singapore acquires stake in India subsidiary for $37.2 million

Taiwanese electronics manufacturer increases its stake in the India unit as it expands iPhone production and accelerates investments in artificial intelligence and advanced manufacturing

Recordent launches credit registry for non-profit MFIs to curb defaults

Recordent CEO and Co-Founder Winny Patro said Section 8 MFIs, which operate as not-for-profit entities, currently manage an estimated Rs 4,000 crore of assets

Centre scraps Jackson Labs' licences amid Rajasthan maternal deaths probe

WHO has sought additional information after reports linked suspected fake oxytocin injections to maternal deaths in Rajasthan, while the Centre cancelled the firm's licences

Unilever explores bid for Thorne amid beauty and wellness expansion

Consumer goods giant is among bidders for US supplements maker Thorne, reportedly valued at up to $4 billion, as it accelerates its shift towards health and wellness

Zydus, Sunshine Healthcare form $20-million JV for Sri Lanka pharma plant

The joint venture will invest over $20 million in a pharmaceutical manufacturing facility in Sri Lanka to boost local drug production and reduce reliance on imports

Fidelity Investments buys 2% stake in Lodha Developers for ₹1,864 crore

The transactions were executed in eight separate tranches on Thursday at an average price of Rs 937.85 apiece, taking the combined transaction value to Rs 1,864.56 crore

Overlooking India means missing the defining growth story: Rajan Mittal

Mittal believes that amid reshaping of the global order, India stands out as a rare bright spot of growth and stability

Apple supplier Tata Electronics tightens security after data breach

The response protocols were deployed immediately, and the incident has had no impact on our operations across businesses, which remain unaffected, the company said

Top 10 Indian firms' value jumps 3.5x in a decade; financials dominate

Reliance Industries has emerged as India's most valuable company over the past five years, while financial services firms continue to dominate the country's corporate rankings

Zydus, Sunshine Healthcare form JV for pharma manufacturing in Sri Lanka

The company has entered into a share subscription and shareholders' agreement (SSSHA) with Sunshine Healthcare Lanka Ltd (Sunshine) and Zydus Sunshine Lifesciences (Pvt) Ltd (Zydus Sunshine)

DRL gets 7 observations after USFDA inspection of Hyderabad biologics plant

USFDA completed a pre-license inspection of the Hyderabad facility and issued a Form 483 with seven observations, which the company said it will address within the stipulated timeline

Alembic Pharma gets USFDA nod for drug to treat influenza A and B in babies

The drug that has received the final approval from the US regulatory body is Oseltamivir Phosphate for Oral Suspension, 6 mg/mL

Vedanta unit accepts bids worth $1.75 bn for 3-tranche dollar debt: Bankers

The bonds will be guaranteed by the parent firm as well as subsidiaries Twin Star Holdings, Welter Trading and Vedanta Holdings Mauritius II